https://scholars.lib.ntu.edu.tw/handle/123456789/562995
標題: | Characteristic clinicopathologic features of epstein-barr virus—associated peripheral T-cell lymphoma | 作者: | ANN-LII CHENG Ih-Jen Su YAO-CHANG CHEN Wu-Ching Uen Chiu-Hwa Wang |
公開日期: | 1993 | 卷: | 72 | 期: | 3 | 起(迄)頁: | 909-916 | 來源出版物: | Cancer | 摘要: | Background. The authors previously reported the existence of a unique subtype of peripheral T?cell lymphoma (PTCL) characterized by a clonotypical proliferation of Epstein?Barr virus (EBV) in the tumor cells (Blood 1991; 77:799). Detailed clinicopathologic features of this newly recognized entity remain to be clarified. Methods. A retrospective study was done in 23 patients receiving consecutive diagnoses at National Taiwan University Hospital by methods previously described. Results. There were 13 male and 10 female patients, with a median age of 40 years. Seventeen patients had Stage III/IV disease, and 15 patients had fever as a presenting B symptom. Initial extranodal involvement occurred in skin (10 patients), lung (4 patients), bone marrow (4 patients), brain (3 patients), and nasal cavity (1 patient) and was evidenced by hepatosplenomegaly (6 patients). Sixteen patients had specific histopathologic features including characteristics similar to angioimmunoblastic lymphadenopathy with dysproteinemia (3 patients), angioinvasive?type features (6 patients), Hodgkin disease–like features (2 patients), hepatosinusoidal?type features (2 patients), Lennert lymphoma (2 patients), and malignant histiocytosis?like features (1 patient). Six (37.5%) of the 16 patients who received a standard regimen with cyclophosphamide, doxorubicin, vincristine, and prednisone or an equivalent regimen as induction chemotherapy achieved complete remission. The median survival time was only 8 months. Six (42.8%) of the 14 patients who have died at this report ended up with a terminal hemophagocytosis syndrome. All five relapsed tumors were found to have a strong expression of P?glycoprotein (P?gp). Conclusions. The authors suggest that EBV?associated PTCL should be regarded as a separate entity of non?Hodgkin lymphoma showing characteristic histopathologic features, frequent expression of P?gp in relapsed tumor, a terminal hemophagocytosis syndrome, and a generally ominous outcome. Copyright ? 1993 American Cancer Society |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/562995 | ISSN: | 0008-543X | DOI: | 10.1002/1097-0142(19930801)72:3<909 | SDG/關鍵字: | adult; article; cancer classification; cancer diagnosis; clinical article; clinical feature; epstein barr virus; female; histopathology; human; human tissue; male; nonhodgkin lymphoma; priority journal; t cell lymphoma; t lymphocyte; Adolescent; Adult; Aged; Antibodies, Viral; Carrier Proteins; Child; Child, Preschool; Female; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Human; Lymphoma, T-Cell, Peripheral; Male; Membrane Glycoproteins; Middle Age; Neoplasm Proteins; Neoplasm Staging; P-Glycoprotein; Retrospective Studies; Support, Non-U.S. Gov't; Survival Rate; Tumor Virus Infections |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。